PYC pyc therapeutics limited

And now Novartis has come back to Alnylam for a discovery-stage...

  1. 6,296 Posts.
    lightbulb Created with Sketch. 22341
    And now Novartis has come back to Alnylam for a discovery-stage partnership, seeking an RNAi solution to end-stage liver failure.

    https://www.biopharmadive.com/news/novartis-alnylam-liver-failure-rna-research/616736/

    https://www.fiercebiotech.com/biotech/novartis-taps-alnylam-for-ambitious-push-to-fix-liver-function
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.15
Change
0.020(1.77%)
Mkt cap ! $670.7M
Open High Low Value Volume
$1.15 $1.18 $1.11 $172.3K 151.3K

Buyers (Bids)

No. Vol. Price($)
1 592 $1.15
 

Sellers (Offers)

Price($) Vol. No.
$1.16 4211 1
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.